Author correction to ‘Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo’ [Acta Pharmaceutica Sinica B 11 (2021) 3950e3965]
作者机构：Department of Orthopaedic Trauma and MicrosurgeryZhongnan Hospital of Wuhan UniversityWuhan 430072China Department of Biochemistry and Molecular MedicineUC Davis School of MedicineSacramentoCA 95817USA
出 版 物：《Acta Pharmaceutica Sinica B》 (药学学报（英文版）)
年 卷 期：2023年第13卷第8期
页 面：3577-3578页
核心收录：
学科分类：050302[文学-传播学] 1007[医学-药学(可授医学、理学学位)] 05[文学] 0503[文学-新闻传播学] 10[医学]
主 题：journal correction replace
摘 要：The authors regret that there was one incorrect image used within Fig.4A,143B cells treated with LSA at 24 h time point,which was obtained from vehicle group but mislabelled as LSA in the *** our studies,three biological replicates were included in each treatment group and at least three images were taken for different fields of each *** thus selected a correct representative image from the LSA treated 143B cells at 24 h time point to replace that mislabelled image,and the updated Fig.4 is provided *** authors apologize for any inconvenience caused to the journal and readers,while this correction does not affect any results and *** authors have provided the original data of this figure to Editorial Office,and the corresponding authors or the Editorial Office can be contacted for original data access.
维普期刊数据库